Dendritic cells in vivo: a key target for a new vaccine science - PubMed (original) (raw)

Dendritic cells in vivo: a key target for a new vaccine science

Ralph M Steinman. Immunity. 2008.

Free article

Abstract

Dendritic cells (DCs) are the antigen presenting cells that initiate and regulate immunity. By studying these cells in vivo, we will be able to move beyond standard approaches and design vaccines that directly harness the elaborate properties of DCs to control immunity.

PubMed Disclaimer

Similar articles

• Enhancement of dendritic cell-based vaccine potency by anti-apoptotic siRNAs targeting key pro-apoptotic proteins in cytotoxic CD8(+) T cell-mediated cell death.
  Kim JH, Kang TH, Noh KH, Bae HC, Kim SH, Yoo YD, Seong SY, Kim TW. Kim JH, et al. Immunol Lett. 2009 Jan 29;122(1):58-67. doi: 10.1016/j.imlet.2008.12.006. Epub 2009 Jan 9. Immunol Lett. 2009. PMID: 19135479
• Dendritic cells from bench to bedside and back.
  Adema GJ. Adema GJ. Immunol Lett. 2009 Feb 21;122(2):128-30. doi: 10.1016/j.imlet.2008.11.017. Epub 2008 Dec 31. Immunol Lett. 2009. PMID: 19121337 Review.
• A high-throughput microparticle microarray platform for dendritic cell-targeting vaccines.
  Acharya AP, Clare-Salzler MJ, Keselowsky BG. Acharya AP, et al. Biomaterials. 2009 Sep;30(25):4168-77. doi: 10.1016/j.biomaterials.2009.04.032. Epub 2009 May 28. Biomaterials. 2009. PMID: 19477505
• Biomaterials as vaccine adjuvants.
  Jones KS. Jones KS. Biotechnol Prog. 2008 Jul-Aug;24(4):807-14. doi: 10.1002/btpr.10. Biotechnol Prog. 2008. PMID: 19194892 Review.
• Lung dendritic cells: targets for therapy in allergic disease.
  Lambrecht BN, Hammad H. Lambrecht BN, et al. Handb Exp Pharmacol. 2009;(188):99-114. doi: 10.1007/978-3-540-71029-5_5. Handb Exp Pharmacol. 2009. PMID: 19031023 Review.

Cited by

• In situ endoscopic photodynamic therapy combined with immature DC vaccination induces a robust T cell response against peritoneal carcinomatosis.
  Degavre C, Lepez A, Ibanez S, François C, Głowacka K, Guilbaud C, Laloux-Morris F, Esfahani H, Brusa D, Bouzin C, Feron O. Degavre C, et al. J Immunother Cancer. 2024 Nov 5;12(11):e009752. doi: 10.1136/jitc-2024-009752. J Immunother Cancer. 2024. PMID: 39500528 Free PMC article.
• Langerhans Cells in Sentinel Lymph Nodes from Melanoma Patients.
  Gerlini G, Susini P, Sestini S, Brandani P, Giannotti V, Borgognoni L. Gerlini G, et al. Cancers (Basel). 2024 May 16;16(10):1890. doi: 10.3390/cancers16101890. Cancers (Basel). 2024. PMID: 38791968 Free PMC article. Review.
• Rapid protection against viral infections by chemokine-accelerated post-exposure vaccination.
  Heine A, Lemmermann NAW, Flores C, Becker-Gotot J, Garbi N, Brossart P, Kurts C. Heine A, et al. Front Immunol. 2024 Jan 29;15:1338499. doi: 10.3389/fimmu.2024.1338499. eCollection 2024. Front Immunol. 2024. PMID: 38348028 Free PMC article.
• Durable CD8 T Cell Memory against SARS-CoV-2 by Prime/Boost and Multi-Dose Vaccination: Considerations on Inter-Dose Time Intervals.
  Natalini A, Simonetti S, Sher C, D'Oro U, Hayday AC, Di Rosa F. Natalini A, et al. Int J Mol Sci. 2022 Nov 19;23(22):14367. doi: 10.3390/ijms232214367. Int J Mol Sci. 2022. PMID: 36430845 Free PMC article. Review.
• Overexpression of VEGF in the MOPC 315 Plasmacytoma Induces Tumor Immunity in Mice.
  Kim BG, Choi SH, Letterio JJ, Song JY, Huang AY. Kim BG, et al. Int J Mol Sci. 2022 May 7;23(9):5235. doi: 10.3390/ijms23095235. Int J Mol Sci. 2022. PMID: 35563626 Free PMC article.

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science
  • Ovid Technologies, Inc.

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information